Ascletis Plans China Submission After Positive Denifanstat Phase III Acne Results

Validation Of FASN Inhibition Approach

 
• By Sushmita Panda
  
Acne
Promising Phase III results in China trial for Ascletis/Sagimet's novel acne contender. (Shutterstock)

More from Dermatological

More from Therapy Areas